Targinta AB
Biotechnology Research
Lund, Skåne Län, Se
1 employees
- Employees
- 1
- Contacts
- 1
- Emails
- 1
Targinta AB Overview
- Headquarters
- Lund, Skåne Län, Se
- Website
- www.targinta.se
- Industry
- Biotechnology Research
- Employees
- 1
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Targinta AB
Targinta is a preclinical stage oncology biotech company, developing first-in-class therapeutic antibodies and ADCs for treatment of aggressive cancers, such as glioblastoma and triple-negative breast cancer, based on a unique and patent-protected target. The pipeline includes TARG10, which is a function-blocking antibody in preclinical development targeting integrin α10. In addition, Targinta’s pipeline includes TARG9, an antibody-drug conjugate (ADC) targeting integrin α10. Targinta is a wholly owned subsidiary of Xintela AB (publ) and is headquartered in Lund, Sweden.
Targinta AB Contact Details
- People in AeroLeads
- 1
- With contact data
- 1
- Email contacts
- 1
- 100.0% coverage
Targinta AB Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Greg Batcheller | Brussels, Brussels Region, Belgium |
Email
|
Compare Similar Companies to Targinta AB
BioGaia AB
Biotechnology Research
SAGA Diagnostics
Biotechnology Research
RG DISCOVERY
Pharmaceutical Manufacturing
Medicon Village
Research Services
Cantargia AB
Biotechnology Research
Alligator Bioscience AB
Biotechnology Research
Truly Labs
Pharmaceutical Manufacturing
Redoxis AB
Research Services
Xintela AB
Biotechnology Research
Sinntaxis
Public Health